Effect of Scutellarin on the Pharmacokinetics and Pharmacodynamics of Warfarin in Rats

Abstract

The study aims to investigate the pharmacodynamics and pharmacokinetics to elucidate the mechanism of enhanced anticoagulant effect of scutellarin and its preparations on warfarin. Evaluation of pharmacodynamic effects is undertaken by measuring coagulation parameters prothrombin time (PT) and activated partial thromboplastin time (APTT). The UHPLC-ESI-MS/MS method is used to determine the plasma concentrations of R/S-warfarin to investigate the influence on the pharmacokinetics. Changes in the plasma protein binding rate of warfarin is studied by ultrafiltration. The results of pharmacodynamics showed that there was no significant difference in PT, international normalized ratio (INR), and APTT between the scutellarin control and the blank control group. Compared to the warfarin control group, scutellarin co-administered with the warfarin group has a significant increase in PT and INR after 8 h, and APTT had no change. The pharmacokinetic results showed that there was an increase in peak concentration (C _max) and area under curve (AUC _0-t and AUC _0–∞) and a significant prolongation of half time (t _1/2) and a decrease in apparent clearance (CL/F) of R-warfarin compared with the warfarin control group. Compared with the warfarin group, the protein binding rates were decreased in all doses of scutellarin co-administered with the warfarin groups, respectively. Scutellarin can enhance the anticoagulant effect of warfarin by both inhibition of the R-warfarin metabolism and reduction in the protein binding rate of warfarin.

Keywords

warfarin - Erigeron breviscapus - Asteraceae - scutellarin - pharmacodynamics - pharmacokinetics - plasma protein binding rate

Publication History

Received: 03 March 2025

Accepted after revision: 11 November 2025

Article published online:
08 December 2025

• References

• 1 Routledge PA, Chapman PH, Davies DM, Rawlins MD. Pharmacokinetics and pharmacodynamics of warfarin at steady state. Br J Clin Pharmacol 1979; 8: 243-247
• 2 Naidong W, Ring PR, Midtlien C, Jiang X. Development and validation of a sensitive and robust LC-tandem MS method for the analysis of warfarin enantiomers in human plasma. J Pharm Biomed Anal 2001; 25: 219-226
• 3 OʼReilly RA. Studies on the optical enantiomorphs of warfarin in man. Clin Pharmacol Ther 1974; 16: 348-354
• 4 Wieland E, Shipkova M. Pharmacokinetic and pharmacodynamic drug monitoring of direct-acting oral anticoagulants: Where do we stand?. Ther Drug Monit 2019; 41: 180-191
• 5 Zhuang W, Liu S, Zhao X, Sun N, He T, Wang Y, Jia B, Lin X, Chu Y, Xi S. Interaction between Chinese medicine and warfarin: Clinical and research update. Front Pharmacol 2021; 12: 751107
• 6 Hamilton Sr. D, Nandkeolyar S, Lan H, Desai P, Evans J, Hauschild C, Choksi D, Abudayyeh I, Contractor T, Hilliard A. Amiodarone: A comprehensive guide for clinicians. Am J Cardiovasc Drugs 2020; 20: 549-558
• 7 Elango K, Javaid A, Khetarpal BK, Ramalingam S, Kolandaivel KP, Gunasekaran K, Ahsan C. The effects of warfarin and direct oral anticoagulants on systemic vascular calcification: A review. Cells 2021; 10: 773
• 8 Hong C, Chen J, Lu M, Sun Y, Qiao H. Simultaneous determination of scutellarin and baicalin in the flowers of Scutellaria Baicalensis Georgi by HPLC. Chin J Mod Appl Pharm 2020; 37: 1320-1323
• 9 Yao H, Li S, Hu J, Chen Y, Huang L, Lin J, Li G, Lin X. Chromatographic fingerprint and quantitative analysis of seven bioactive compounds of Scutellaria barbata . Planta Med 2011; 77: 388-393
• 10 Liu CZ, Gao M, Guo B. Plant regeneration of Erigeron breviscapus (vant.) Hand. Mazz. and its chromatographic fingerprint analysis for quality control. Plant Cell Rep 2008; 27: 39-45
• 11 Wang W, Ma X, Han J, Zhou M, Ren H, Pan Q, Zheng C, Zheng Q. Neuroprotective effect of Scutellarin on ischemic cerebral injury by down-regulating the expression of angiotensin-converting enzyme and AT1 receptor. PLoS One 2016; 11: e0146197
• 12 Xiong LL, Du RL, Xue LL, Jiang Y, Huang J, Chen L, Liu J, Wang TH. Anti-colorectal cancer effects of scutellarin revealed by genomic and proteomic analysis. Chin Med 2020; 15: 28
• 13 Long L, Wang J, Lu X, Xu Y, Zheng S, Luo C, Li Y. Protective effects of scutellarin on type II diabetes mellitus-induced testicular damages related to reactive oxygen species/Bcl-2/Bax and reactive oxygen species/microcirculation/staving pathway in diabetic rat. J Diabetes Res 2015; 2015: 252530
• 14 Wen L, He T, Yu A, Sun S, Li X, Wei J, Song R, Yan X, Li R, Ren X, Wang Y, Liu X, Dong Y, Fu X, She G. Breviscapine: A review on its phytochemistry, pharmacokinetics and therapeutic effects. Am J Chin Med 2021; 49: 1369-1397
• 15 Chen HD, Jiang MZ, Zhao YY, Li X, Lan H, Yang WQ, Lai Y. Effects of breviscapine on cerebral ischemia-reperfusion injury and intestinal flora imbalance by regulating the TLR4/MyD88/NF-κB signaling pathway in rats. J Ethnopharmacol 2023; 300: 115691
• 16 Xiang JJ, Yao SY, Xie YM, Zhao YQ. The safety research on Dengzhanxixin injection. Guangdong Med J 2018; 39: 458-462
• 17 Gao J, Chen G, He H, Liu C, Xiong X, Li J, Wang J. Therapeutic effects of breviscapine in cardiovascular diseases: A review. Front Pharmacol 2017; 8: 289
• 18 Lyu J, Xie Y, Sun M, Zhang L. Clinical evidence and GRADE assessment for breviscapine injection (DengZhanHuaSu) in patients with acute cerebral infraction. J Ethnopharmacol 2020; 262: 113137
• 19 Sun X, Zhou L, Han Y, Yang Q, Li X, Xin B, Chi M, Wang Y, Guo C. Scutellarin attenuates doxorubicin-induced cardiotoxicity by inhibiting myocardial fibrosis, apoptosis and autophagy in rats. Chem Biodivers 2023; 20: e202200450
• 20 Duan H, Zhang Q, Liu J, Li R, Wang D, Peng W, Wu C. Suppression of apoptosis in vascular endothelial cell, the promising way for natural medicines to treat atherosclerosis. Pharmacol Res 2021; 168: 105599
• 21 Xu LJ, Chen RC, Ma XY, Zhu Y, Sun GB, Sun XB. Scutellarin protects against myocardial ischemia-reperfusion injury by suppressing NLRP3 inflammasome activation. Phytomedicine 2020; 68: 153169
• 22 Zhuang Q, Chen L, Wu W, Wang Q, Kang C, Xiong Y, Huang X. Scutellarin ameliorates ischemia/reperfusion-mediated endothelial dysfunction by upregulating cathepsin D expression to rescue autophagy-lysosomal function. Front Pharmacol 2025; 16: 1538697
• 23 Zhou L, Guo SN, Gao Y. Effects and perspectives of Chinese patent medicines for tonifying Qi and promoting blood circulation on patients with cerebral infarction. Curr Vasc Pharmacol 2015; 13: 475-491
• 24 Wang L, Ma Q. Clinical benefits and pharmacology of scutellarin: A comprehensive review. Pharmacol Ther 2018; 190: 105-127
• 25 Wang C, Li Y, Gao S, Cheng D, Zhao S, Liu E. Breviscapine injection improves the therapeutic effect of western medicine on angina pectoris patients. PLoS One 2015; 10: e0129969
• 26 Lu PF, Zeng XB, Xie YM, Yang W, Li YY, Yang W, Wang ZG. Explore dengzhan xixin injection effecting on outcome of coronary heart disease based on propensity score. Zhongguo Zhong Yao Za Zhi 2013; 38: 3121-3128
• 27 Shen H, Yang W, Xie YM, Zeng XB. Exploration of clinical outcomes on coronary heart disease of parenterally administered dengzhan xixin using propensity score. Chin J Chin Mater Med 2013; 38: 3166-3171
• 28 Huang H, Cao C, Miao Z, Yang X, Lai Y. Scutellarin mediates cytochrome P450 3A4 and 2C19 expression via pregnane X receptor and constitutive androstane receptor. Curr Mol Pharmacol 2023; 16: 640-653
• 29 Jian TY, He JC, He GH, Feng EF, Li HL, Bai M, Xu GL. Scutellarin inhibits cytochrome P450 isoenzyme 1A2 (CYP1A2) in rats. Phytother Res 2012; 26: 1226-1230
• 30 Lin Z, Guo S, Yang C, Yu Y, Xu L, Liu G. In vivo effects of scutellarin on the activities of CYP1A2, CYP2C11, CYP2D1, and CYP3A1/2 by cocktail probe drugs in rats. Pharmazie 2014; 69: 537-541
• 31 Zhou L, Ju WZ, Liu ZX, Tan HS. Determination of plasma protein binding rate of multicomponent in Dengzhanxixin injection. Chin Pharmacol Bull 2011; 27: 719-722
• 32 Jiang M, Zhou Y, Chen J, Zhang W, Sun Z, Qin M, Liu Y, Liu G. Effects of Herba Erigerontis injection on pharmacodynamics and pharmacokinetics of warfarin in rats in vivo . Basic Clin Pharmacol Toxicol 2021; 128: 386-393
• 33 Liu Y, Liu S, Shi Y, Qin M, Sun Z, Liu G. Effects of safflower injection on the pharmacodynamics and pharmacokinetics of warfarin in rats. Xenobiotica 2018; 48: 818-823
• 34 Shi Y, Zhang W, Jiang M, Huang L, Zhou Y, Chen J, Liu D, Liu G, Dong M. Effects of sulfotanshinone sodium injection on the pharmacokinetics and pharmacodynamics of warfarin in rats in vivo . Xenobiotica 2020; 50: 705-712